FDA Adverse Event Malfunction Summary report: N

ILET BIONIC PANCREAS

MDR report key: 23600740 · Received November 19, 2025

Report

Report Number
3019004087-2025-08700
Event Type
Malfunction
Date Received
November 19, 2025
Date of Event
July 4, 2024
Report Date
November 19, 2025
Manufacturer
BETA BIONICS INC.
Product Code
QFG
UDI-DI
850050080015
PMA / PMN Number
K231485
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THIS MDR IS PART OF A REMEDIAL SUBMISSION MADE IN RESPONSE TO FDA FORM 483 OBSERVATIONS TO ENSURE FULL REPORTING COMPLIANCE.

Description of Event or Problem · 0

ON (B)(6) 2024 AT APPROXIMATELY 4:45 PM PST, THE PATIENT REPORTED ELEVATED BLOOD GLUCOSE LEVELS FOLLOWING A SUPPLY AND INFUSION SITE CHANGE EARLIER THAT MORNING. BLOOD GLUCOSE WAS STABLE THROUGHOUT THE DAY UNTIL AFTER DINNER (BLT SANDWICH) APPROXIMATELY 1 HOUR AND 45 MINUTES PRIOR TO THE CALL. THE PATIENT ANNOUNCED THE MEAL AT THE TIME OF EATING. REPORTED BLOOD GLUCOSE RANGED BETWEEN 200¿318 MG/DL FOR ABOUT 1.25 HOURS, WITH THE HIGHEST READING AT 318 MG/DL. THE PATIENT ATTEMPTED A MEAL ANNOUNCEMENT AS A CORRECTION, WHICH THE AGENT ADVISED AGAINST AND PROVIDED EDUCATION ON PROPER CORRECTION METHODS. NO KETONE TESTING WAS PERFORMED, AND NO BACKUP THERAPY OR PROFESSIONAL MEDICAL INTERVENTION WAS REQUIRED. THE PATIENT REPORTED NO IMMEDIATE HEALTH EFFECTS (E.G., DIZZINESS, DKA). AGENT ADVISED MONITORING BLOOD GLUCOSE AND TO CALL BACK IF LEVELS REMAINED AT OR ABOVE 300 MG/DL FOR FURTHER TROUBLESHOOTING. PATIENT UNDERSTOOD AND AGREED. CASE CLOSED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2468023 ILET BIONIC PANCREAS ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP QFG BETA BIONICS INC. BB1001 850050080015

Patients

Seq Age Sex Outcome Treatment
1 74 YR Unknown